Cargando…
HIPGEN: a randomized, multicentre phase III study using intramuscular PLacenta-eXpanded stromal cells therapy for recovery following hip fracture arthroplasty: a study design
AIMS: The aim of the HIPGEN consortium is to develop the first cell therapy product for hip fracture patients using PLacental-eXpanded (PLX-PAD) stromal cells. METHODS: HIPGEN is a multicentre, multinational, randomized, double-blind, placebo-controlled trial. A total of 240 patients aged 60 to 90 y...
Autores principales: | Winkler, Tobias, Costa, Matthew L., Ofir, Racheli, Parolini, Ornella, Geissler, Sven, Volk, Hans-Dieter, Eder, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044085/ https://www.ncbi.nlm.nih.gov/pubmed/35451865 http://dx.doi.org/10.1302/2633-1462.34.BJO-2021-0156.R1 |
Ejemplares similares
-
Volume and location of bone regeneration after autologous expanded mesenchymal stromal cells in hip osteonecrosis: a pilot study
por: Gómez-Barrena, Enrique, et al.
Publicado: (2022) -
Intramuscular and intratendinous placenta‐derived mesenchymal stromal‐like cell treatment of a chronic quadriceps tendon rupture
por: Maleitzke, Tazio, et al.
Publicado: (2022) -
Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine
por: Papait, Andrea, et al.
Publicado: (2020) -
Immunomodulatory placental‐expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty
por: Winkler, Tobias, et al.
Publicado: (2018) -
Placenta-Expanded Stromal Cell Therapy in a Rodent Model of Simulated Weightlessness
por: Rubinstein, Linda, et al.
Publicado: (2021)